Skip to main content
. 2018 Sep 7;9:421. doi: 10.3389/fpsyt.2018.00421

Table 4.

All participants' ERP P3 mean latencies [mean (SD), ms] and mean amplitudes [mean (SD), μV] *.

Scalp regions IAG NCG
Compatible trials Incompatible trials Compatible trials Incompatible trials
Latencies Amplitudes Latencies Amplitudes Latencies Amplitudes Latencies Amplitudes
Frontal lobe 297 (18) 4.5 (0.6) 296 (15) 4.4 (0.7) 296 (18) 4.5 (0.8) 300 (9) 4.8 (1.0)
Parietal lobe 296 (19) 4.6 (0.8) 302 (12) 4.7 (0.9) 301 (11) 4.6 (0.7) 305 (17) 4.9 (0.6)
Central lobe 301 (16) 4.5 (0.9) 299 (17) 4.7 (0.8) 297 (15) 4.7 (0.6) 297 (13) 4.7 (0.7)
Temporal lobe (T3) 295 (14) 4.8 (0.7) 298 (13) 4.9 (0.9) 304 (16) 4.8 (0.7) 302 (18) 4.9 (0.9)
Temporal lobe (T4) 294 (17) 4.5 (1.0) 303 (16) 4.8 (0.6) 301 (12) 5.0 (0.6) 298 (16) 5.0 (0.6)
Occipital lobe 299 (16) 6.8 (0.9) 302 (17) 4.8 (0.8) 297 (18) 4.6 (0.9) 306 (16) 4.8 (0.8)
*

The sum of all corresponding scalp region latencies and amplitudes divided by numbers of electrode sites are the mean latencies and mean amplitudes, respectively.